Check-Cap (MBAI) Stock Analysis: AI Score & Alternative Data
MBAI alt-data: sentiment climbing, business outlook lagging
Is Check-Cap a buy right now? The alternative data says hold. This MBAI stock analysis is built on the 25+ alternative data signals AltIndex tracks on Check-Cap every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 48/100: a Hold. The stock trades at $8.83.
The bullish side of the 90-day ledger: sentiment up 9.9% to 100/100. The drag: just 46% of employees report a positive business outlook, and Reddit mentions down 97.9% to 2 a day. That tension is what keeps the score mid-range.
MBAI’s broader alt-data profile also covers headcount (28 employees, according to LinkedIn), and web traffic (11 monthly visits). Every signal links to its own page with full history, the MBAI technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on MBAI is just below.
Check-Cap AI Stock Analysis
Check Cap Ltd. is a biotechnology company that is engaged in the development and commercialization of medical diagnostic products. The company is focused on advancing the early detection and preventive care of colorectal cancer through its pioneering technology, which facilitates the identification of precancerous polyps and early-stage carcinoma.
Analysis generated August 1, 2026.
Recent Check-Cap Stock Alerts
|
Check-Cap | August 13 Price is up by 589% in the last 24h. |
|
Check-Cap | August 12 Price is up by 6.3% in the last 24h. |
|
Check-Cap | August 11 Price is down by -7.3% in the last 24h. |
|
Check-Cap | August 10 Price is down by -9.2% in the last 24h. |
Check-Cap Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 11 | 0% | |
| LinkedIn Employees | 28 | 3.4% | |
| Employee Recommend | 100 | 0% | |
| Business Outlook | 46 | 0% | |
| Sentiment | 100 | 9.9% | |
| Reddit Mentions | 2 | 97.9% | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 36 | 81.6% | |
| News Mentions | 67 | 81.1% | |
| Stocktwits Subscribers | 19K | 0.8% |
About Check-Cap (MBAI)
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company is headquartered in Isfiya, Israel.
| Price | $8.83 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | — |
| Year Range | $1 – $9 |
| Dividend Yield | 0% |
| PE Ratio | 0.3 |
| Analyst Rating | 38% buy |
| Industry | Health Care Services |
Latest Check-Cap News
View more →
Check-Cap Advances MBody AI Merger; Reverse Share SplitAugust 11 - Financial Post |
|
Check-Cap Announces Reverse Share SplitAugust 7 - Financial Post |
|
Check-Cap: MBody AI Takes Autonomous Services Outdoors, Expanding Addressable MarketAugust 6 - Financial Post |
|
Check-Cap (MBAI) Sets Eight-Week Target for MBody AI MergerAugust 5 - Financial Post |
|
Check-Cap files to sell ordinary shares, no amount givenJuly 24 - Thefly.com |
Check-Cap Earnings & Financial Performance
View all earnings →Check-Cap Insider Trading Activity
View all →| No recent insider transactions on file. |
Check-Cap Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Check-Cap
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
bioAffinity TechnologiesBIAF |
$0.38 19.0% | $3M | 0 |
 |
NewGenIvf GroupNIVF |
$0.55 5.0% | $3M | 52 |
 |
iSpecimenISPC |
$2.30 1.3% | $3M | 43 |
 |
Inspire Veterinary PartnersIVP |
$0.03 16.1% | $4M | 40 |
 |
ENDRA Life SciencesNDRA |
$4.47 0.0% | $6M | 46 |
Explore Check-Cap Data
Frequently Asked Questions: Check-Cap (MBAI)
Check-Cap has an AltIndex AI Score of 48/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
48/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Check-Cap (MBAI) stock is $8.83 with a market cap of —.
As of today, Check-Cap’s PE (Price to Earnings) ratio is 0.3.
View the latest Check-Cap insider transactions to see recent buying and selling activity by company executives and directors.
Check the Check-Cap congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The MBAI stock price chart above shows Check-Cap’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Check-Cap technical analysis for RSI, moving averages, and more.
See the stocks similar to Check-Cap section on this page for companies in the same industry ranked by market cap and AI Score.
